Psoriasis in pregnancy: A review of most important literature data

Acta Dermatovenerologica Croatica

Volumn 17, Issue 3, 2009, Pages 193-197

  Čeović, Romana ^a   Lipozenčić, Jasna ^a   Pašić, Aida ^a   Kostović, Krešimir ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Pre pregnancy period; Pregnancy; Psoriasis; Safe therapeutic options

Indexed keywords

CALCIPOTRIOL; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; EMOLLIENT AGENT; ETRETIN; ETRETINATE; ISOTRETINOIN; METHOTREXATE; METHOXSALEN; PSORALEN; RETINOID DERIVATIVE; RETINOL DERIVATIVE; SALICYLIC ACID; TACROLIMUS; TAZAROTENE;

ABSENCE OF SIDE EFFECTS; ACNE; BIOLOGICAL THERAPY; CLEFT PALATE; DELIVERY; DISEASE EXACERBATION; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG POTENCY; DRUG SAFETY; HUMAN; LOW BIRTH WEIGHT; NEPHROTOXICITY; NONHUMAN; PREGNANCY; PREMATURITY; PSORIASIS; PUERPERIUM; PUVA; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SKELETON MALFORMATION; SPONTANEOUS ABORTION; STEROID THERAPY; TERATOGENICITY; TOPICAL TREATMENT; ULTRAVIOLET B RADIATION;

FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PSORIASIS;

EID: 70349664339     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes and Immunity 2007:8;1-12. (Pubitemid 46158098)
2. Lowes AM, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature online publication /V6/: 445 (22 February 2007) doi:10.138/nature 05663
3. Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Psoriasis and pregnancy. J Cutan Med Surg 2002;6:561-570
4. Swanbeck G, Inerot A, Martinsson T. A population genetic study of psoriasis. Br J Dermatol 1994;131:32-39
5. Barker J. Genetic aspects of psoriasis. Clin Exp Dermatol 2001;26:321-325
6. Dunna SF, Finlay AY. Psoriasis: improvement during and worsening after pregnancy. Br J Dermatol 1989;120:584.
7. Raychaudhuri SP, Navare T, Gross J, Raychaudhuri SK. Clinical course of psoriasis during pregnancy. Int J Dermatol 2003;42:518-520
8. Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein MD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol 2005;141:601-606
9. Boyd AS, Morris LF, Phillips CM. Psoriasis and pregnancy: hormone and immune system interaction. Int J Dermatol 1996;35:169.
10. Weatherhead S, Robson SC, Reynolds N. Management of psoriasis in pregnancy. BMJ 2007;334:1218-1220
11. Lam J, Polifka JE, Dohil AM. Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases. J Am Acad Dermatol 2008;59:295-315.
12. Gay MW, Moore WJ, Morgan JM. Anthralin toxicity. Arch Dermatol 1972;105:213-215
13. Neill SM, Bugrein A, Coulson IH. Toxicologic study of anthralin in an aqueous cream formulation. Cutis 1984;34:563-566 (Pubitemid 15176231)
14. Moward CM, Margolis DJ, Halpern AC. Hormonal influences on women with psoriasis. Cutis 1998;61:257-260
15. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology 1997;56:335-340 (Pubitemid 28035180)
16. Mygind H, Thulstrup AM, Pedersen L, Larsen H. Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy. Acta Obstet Gynecol Scand 2002;81:234-239 (Pubitemid 34264139)
17. Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996;30:935-940 (Pubitemid 26295242)
18. Schwarb FP, Gabard B, Rufli T, Surber C. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations. Dermatology 1999;198:44-51. (Pubitemid 29086334)
19. de Prost Y. New topical immunological treatments for psorasis. J Eur Acad Dermatol Venereol 2006;20(Suppl):80-82 (Pubitemid 44615014)
20. Martin Ezquerra G, Sanchez Regana M, Herrera Acosta E, Umbert Millet P. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drug Dermatol 2006;5:334-336
21. Soter NA, Fleischer AB, Webster GF. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, Safety. J Am Acad Dermatol 2001;44:S39-S46. (Pubitemid 32047912)
22. Koo YM. Current consensus and update on psoriasis therapy: a perspective from the United States. J Dermatol 1999;26:723-733
23. Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000;43(Suppl): S31-5.
24. Spuls PI, Bossuyt PM, van Everdingen JJ. The development of practice guidelines for the treatment of severe plaque-form psoriasis. Arch Dermatol 1998;134:1591-1596
25. Bridges BA. An estimate of genetic risk from 8-methoxypsoralen photochemotherapy. Hum Genet 1979;49:91-96
26. Gunnarskog JG, Kallen AJ, Lindelof BG. Psoralen photochemotherapy (PUVA) and pregnancy. Arch Dermatol 1993;129:320-323
27. Stern RS, Lange R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol 1991;127:347-350
28. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT. Retinoic acid embryopathy.
29. N Engl J Med 1985;313:837-841
30. Perlman SE, Enny Leach E, Dominiguez L. "Be smart, be safe, be sure": the revised pregnancy prevention program for women on isotretinoin. J Reprod Med 2001;46(2 Suppl):179-185
31. Anstey A, Hawk JLM. Isotretinoin-PUVA in women with psoriasis. Br J Dermatol 1997;136:792-806.
32. Hönigsmann H, Wolff K. Isotretinoin-PUVA for psoriasis. Lancet 1983;1:236.
33. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001;71:1051-1055 (Pubitemid 32448816)
34. Toma H, Tanabe K, Tokumoto T, Kobayashi C, Yagisawa T. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transplant 1999;14:1511-1516 (Pubitemid 29241746)
35. Armenti VT, Moritz MJ, Davison JM. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998;19:219-232
36. Berth-Jones J, Voorhees JJ. Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996. Br J Dermatol 1996;135:775-777 (Pubitemid 26375897)
37. Wright S, Glover M, Baker H. Psoriasis, cyclosporine and pregnancy. Arch Dermatol 1991;27:426.
38. Morris LF, Harrod MJ, Menter MA. Methotrexate and reproduction in men: case report and recommendations. J Am Acad Dermatol 1993;29:913-916 (Pubitemid 23335298)
39. Perry WH. Methotrexate and teratogenesis. Arch Dermatol 1983;119:874.